RxDoctor Payments Data

Dean Brown, OD

Optometrist · Montpelier, IDNPI 1821051400

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.2% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Biotissue Holdings Inc. accounts for 77.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $160 and has fallen 81.8% since, to $29 in 2025. That places this record below the midpoint for optometrist clinicians in ID, where the typical reported total is $633.

$205in general payments, 2019–2025

Across 3 payments — averaging $68.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotissue Holdings Inc.$160
  • Johnson & Johnson Vision Care, Inc.$29
  • Carl Zeiss Meditec, Inc.$16

What the payments were for

  • Food & beverage$18992%
  • Gifts$168%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$205 in reported general payments places this provider in the 20th percentile of 304 optometrist providers in Idaho.

See all optometrist providers in Idaho →

Medicare billing

Part B allowed, 2024
$283,386
Medicare patients
768
Services billed
3,545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost11$70

Paid to pharmacies, not to this prescriber.

Other optometrist in Montpelier

See the full list for Idaho →

Where these figures come from

Is this you, or does something look wrong? →